Inherent genome instability underlies trisomy 21-associated myeloid malignancies
Leukemia · 2024
DOI: 10.1038/s41375-024-02151-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Leukemia, 2024. Verfasst von Chun-Chin Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Transplantation Program, Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Down Syndrome, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemoid Reaction. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI), U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive…, Leukemia and Lymphoma Society (Leukemia & Lymphoma Society).
Abstract (Originalsprache)
Constitutional trisomy 21 (T21) is a state of aneuploidy associated with high incidence of childhood acute myeloid leukemia (AML). T21-associated AML is preceded by transient abnormal myelopoiesis (TAM), which is triggered by truncating mutations in GATA1 generating a short GATA1 isoform (GATA1s). T21-associated AML emerges due to secondary mutations in hematopoietic clones bearing GATA1s. Since aneuploidy generally impairs cellular fitness, the paradoxically elevated risk of myeloid malignancy in T21 is not fully understood. We hypothesized that individuals with T21 bear inherent genome instability in hematopoietic lineages that promotes leukemogenic mutations driving the genesis of TAM and AML. We found that individuals with T21 show increased chromosomal copy number variations (CNVs) compared to euploid individuals, suggesting that genome instability could be underlying predisposition to TAM and AML. Acquisition of GATA1s enforces myeloid skewing and maintenance of the hematopoietic progenitor state independently of T21; however, GATA1s in T21 hematopoietic progenitor cells (HPCs) further augments genome instability. Increased dosage of the chromosome 21 (chr21) gene DYRK1A impairs homology-directed DNA repair as a mechanism of elevated mutagenesis. These results posit a model wherein inherent genome instability in T21 drives myeloid malignancy in concert with GATA1s mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Stem Cell Transplantation Program, Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
- David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
- RA Capital, Boston, MA, USA.
- The Barbara K. Ostrom (1978) Bioinformatics and Computing Facility, Swanson Biotechnology Center, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
- Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
Förderung
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive…
- Leukemia and Lymphoma Society (Leukemia & Lymphoma Society)
- NIDDK NIH HHS
- Alex's Lemonade Stand Foundation for Childhood Cancer (Alex's Lemonade Stand Foundation)
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
- Alex's Lemonade Stand Foundation for Childhood Cancer
- Howard Hughes Medical Institute
Zitieren
APA
Chen, C. C., Silberman, R. E., Ma, D., Perry, J. A., Khalid, D., Pikman, Y., Amon, A., Hemann, M. T., & Rowe, R. G. (2024). Inherent genome instability underlies trisomy 21-associated myeloid malignancies. Leukemia. https://doi.org/10.1038/s41375-024-02151-8
Vancouver
Chen CC, Silberman RE, Ma D, Perry JA, Khalid D, Pikman Y, et al. Inherent genome instability underlies trisomy 21-associated myeloid malignancies. Leukemia. 2024. doi:10.1038/s41375-024-02151-8
BibTeX
@article{Chen2024,
author = {Chen, Chun-Chin and Silberman, Rebecca E and Ma, Duanduan and Perry, Jennifer A and Khalid, Delan and Pikman, Yana and Amon, Angelika and Hemann, Michael T and Rowe, R Grant},
title = {Inherent genome instability underlies trisomy 21-associated myeloid malignancies},
journal = {Leukemia},
year = {2024},
doi = {10.1038/s41375-024-02151-8}
}
EUVIMED